Globeimmune Inc

Write a Review303-625-2700

Headquartered in Louisville, Colo., GlobeImmune is a biopharmaceutical company that develops and manufactures targeted molecular immunotherapies called Tarmogens for the treatment of hepatitis, influenza, fungal infection and cancer. Its GI-5005 product is used for the treatment of chronic hepatitis C infection. The company offers GI-4000 Tarmogen that causes the targeted elimination of cell containing mutations in the ras oncogene. GlobeImmune has exclusive license to more than 80 patents and patent applications worldwide. It has over 15 issued foreign patents. For its cancer treatment products, the company has approximately 50 patents and patent applications worldwide. GlobeImmune maintains a more than 40,000-square-foot laboratory and employs over 50 people. It also participates in clinical trials.